6-14131650-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The ENST00000379153.4(CD83):c.284G>A(p.Arg95Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000335 in 1,614,010 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
ENST00000379153.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD83 | NM_004233.4 | c.284G>A | p.Arg95Gln | missense_variant | 3/5 | ENST00000379153.4 | NP_004224.1 | |
CD83 | NM_001040280.3 | c.284G>A | p.Arg95Gln | missense_variant | 3/5 | NP_001035370.1 | ||
CD83 | NM_001251901.1 | c.107G>A | p.Arg36Gln | missense_variant | 3/5 | NP_001238830.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD83 | ENST00000379153.4 | c.284G>A | p.Arg95Gln | missense_variant | 3/5 | 1 | NM_004233.4 | ENSP00000368450 | P1 | |
CD83 | ENST00000612003.4 | c.107G>A | p.Arg36Gln | missense_variant | 3/5 | 4 | ENSP00000480760 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152126Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000557 AC: 14AN: 251486Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135912
GnomAD4 exome AF: 0.0000198 AC: 29AN: 1461884Hom.: 0 Cov.: 32 AF XY: 0.0000124 AC XY: 9AN XY: 727246
GnomAD4 genome AF: 0.000164 AC: 25AN: 152126Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74318
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 30, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at